Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Liabilities and Shareholders Equity (2022 - 2026)

Kura Oncology has reported Liabilities and Shareholders Equity over the past 5 years, most recently at $652.6 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 12.26% to $652.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.7 billion through Mar 2026, up 9.0% year-over-year, with the annual reading at $738.4 million for FY2025, 2.87% down from the prior year.
  • Liabilities and Shareholders Equity was $652.6 million for Q1 2026 at Kura Oncology, down from $738.4 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $760.2 million in Q4 2024 and troughed at $426.0 million in Q1 2023.
  • The 5-year median for Liabilities and Shareholders Equity is $534.5 million (2024), against an average of $576.7 million.
  • Year-over-year, Liabilities and Shareholders Equity soared 69.32% in 2024 and then dropped 12.26% in 2026.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $456.3 million in 2022, then dropped by 1.62% to $448.9 million in 2023, then surged by 69.32% to $760.2 million in 2024, then decreased by 2.87% to $738.4 million in 2025, then dropped by 11.62% to $652.6 million in 2026.
  • Per Business Quant, the three most recent readings for KURA's Liabilities and Shareholders Equity are $652.6 million (Q1 2026), $738.4 million (Q4 2025), and $649.4 million (Q3 2025).